Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
3
60%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

completed480%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
completed

Evaluation of the Acceptability and Safety of the ShangRing Device for Male Circumcision in Shinyanga, Tanzania

NCT06273696
completednot_applicable

Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision (EIMC) in Sub-Saharan Africa

NCT03338699
withdrawnnot_applicable

Evaluation and Adverse Event Surveillance for Initial Implementation of ShangRing Circumcision in Mozambique

NCT03761836
completednot_applicable

Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia

NCT02242565
completedphase_1

Male Circumcision (MC) Using the ShangRing™ Device in Malawi

NCT02309710

Clinical Trials (5)

Showing 5 of 5 trials
NCT06273696

Evaluation of the Acceptability and Safety of the ShangRing Device for Male Circumcision in Shinyanga, Tanzania

Completed
NCT03338699Not Applicable

Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision (EIMC) in Sub-Saharan Africa

Completed
NCT03761836Not Applicable

Evaluation and Adverse Event Surveillance for Initial Implementation of ShangRing Circumcision in Mozambique

Withdrawn
NCT02242565Not Applicable

Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia

Completed
NCT02309710Phase 1

Male Circumcision (MC) Using the ShangRing™ Device in Malawi

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5